New research shows the positive results of a phase II clinical trial using the oral medication DFMO to prevent relapse in children with High Risk Neuroblastoma (HRNB).
from Latest Science News -- ScienceDaily https://ift.tt/2Nkvr4C
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment